About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about SPRY

Recent news which mentions SPRY

< Previous 1 2 Next >
ARS Pharma (SPRY) Q4 2025 Earnings Transcript
Tickers SPRY
Tags Market News SPRY Recent Press Releases
From Motley Fool
ARS Pharmaceuticals Q1 2026 Earnings Call Transcript
Tickers NEWS SPRY
Tags SPRY Benzinga Market News
From Benzinga
Earnings Scheduled For May 15, 2026
Tickers ARAI AZ BCDA BEEM
Tags Market News Benzinga BNZI
From Benzinga
ARS Pharmaceuticals Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street&#39;s Most Accurate Analysts
Tickers NEWS SPRY
Tags Analyst Ratings Earnings Trading Ideas
From Benzinga
Dow Settles Above 50,000: Investor Sentiment Improves, Fear Index Remains In &#39;Greed&#39; Zone
Tickers CSCO DDS NEWS RBC
Tags Equities News DDS
From Benzinga
ARS Pharma Sales Jump 3,040% in Q2
Tickers SPRY
Tags Market News SPRY Recent Press Releases
From Motley Fool
Earnings Scheduled For August 13, 2025
Tickers AEMD ALLO ALUR ALVO
Tags GAUZ SBC EWCZ
From Benzinga
Earnings Outlook For ARS Pharmaceuticals
Tickers SPRY
Tags BZI/EP SPRY Market News
From Benzinga
Jim Cramer Is All Aboard Union Pacific, But Shows No Love For Orphan Drugs
Tickers BMRN GTLB NEWS OKLO
Tags Analyst Color Markets SMR
From Benzinga
Earnings Scheduled For May 14, 2025
Tickers ADCT AEVA AFCG ALUR
Tags LUCD SMTI ICCC
From Benzinga
ARS Pharmaceuticals's Earnings: A Preview
Tickers SPRY
Tags BZI/EP Earnings SPRY
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Tickers ADAP AKBA BDRX CRVO
Tags AKBA SPRY Market News
From Benzinga
Jabil Posts Better-Than-Expected Earnings, Joins Darden Restaurants, QXO, Five Below And Other Big Stocks Moving Higher On Thursday
Tickers CAPR CLEU CVNA DRI
Tags QXO CAPR CVNA
From Benzinga
Earnings Scheduled For March 20, 2025
Tickers ACN ADAP ALAR AMPX
Tags PDD TELA TNON
From Benzinga
FDA Approves ARS Pharmaceuticals' Lower Dose Neffy Nasal Spray For Emergency Allergy Treatment
Tickers NEWS SPRY
Tags Health Care News FDA
From Benzinga
Earnings Scheduled For November 13, 2024
Tickers ACXP ADAP AEMD AFCG
Tags OWLT TLPH HI
From Benzinga
Insights Ahead: ARS Pharmaceuticals's Quarterly Earnings
Tickers SPRY
Tags Market News SPRY Benzinga
From Benzinga
ARS Pharmaceuticals Inks Licensing Pact For Neffy Allergic Reaction Treatment, Analyst Sees Further Stock Upside Despite 200% Surge In 2024
Tickers NEWS SPRY
Tags Market News SPRY Benzinga
From Benzinga
Where ARS Pharmaceuticals Stands With Analysts
Tickers SPRY
Tags BZI/AAR SPRY Market News
From Benzinga
Analyst Ratings For ARS Pharmaceuticals
Tickers SPRY
Tags Analyst Ratings SPRY Benzinga
From Benzinga
Newly Approved ARS Pharmaceuticals' Needle-Free Neffy Offers Convenience Over EpiPen For Allergic Reaction, But Real-World Efficacy Questioned
Tickers NEWS SPRY
Tags Stories That Matter Biotech General
From Benzinga
ARS Pharmaceuticals 'Neffy Uniquely Positioned With Potential To Change Allergy Treatment Paradigm For First Time In 40 years:' Analyst
Tickers NEWS SNY SPRY
Tags why it's moving Movers General
From Benzinga
Fabrinet Posts Strong Earnings, Joins Amer Sports, Hawaiian Holdings And Other Big Stocks Moving Higher On Tuesday
Tickers AS BTBT FN HA
Tags Trading Ideas NMM ZKH
From Benzinga
Looking Into ARS Pharmaceuticals's Recent Short Interest
Tickers SPRY
Tags Trading Ideas Short Ideas BZI/SHORTHIST
From Benzinga
Loar Holdings Posts Upbeat Results, Joins Nvidia, Clean Energy Fuels, Penumbra And Other Big Stocks Moving Higher On Tuesday
Tickers AILE ASND CLNE CLVT
Tags CLNE SPRY CVNA
From Benzinga
FDA Approves ARS Pharma's Once Rejected Neffy Nasal Spray Alternative To EpiPen For Emergency Allergy Treatment
Tickers NEWS SNY SPRY
Tags General Movers Biotech
From Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.